ARCHIVES

Senate Committee Investigating Pharma’s “Educational Grants.”

This article is from The Cancer Letter archive.

Vol. 32 No. 02 | January 20, 2006

Download PDF Visit The Full Archive

Related Articles

NCI blocked groups from phase III Iressa studies.

April 30, 2004

In Brief: FCRC Committee Loses Chance To influence RFP; Recompetition To Remain On Schedule

November 5, 1976

Senate Legislation Tackles Drug Shortages, Proposes Faster Approval For “Breakthroughs”

April 27, 2012

Analysis Reveals CAIX Subgroup Responsive to Rencarex Therapy

June 28, 2013

NCI to Recompete contracts for Frederick

December 4, 1992

In Brief: LSU Will Be Headquarters For National Pancreatic Project; Budget For First Year Will Be $1 Million

December 6, 1974